Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study

Several studies have strengthened the link between the gut microbiota (GM) and the response to immunotherapy in patients with tumors, highlighting the potential role of GM as a biomarker of response. Targeted therapies including B-cell receptor (BCR) inhibitors (BCRi) represent the newest approach t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuccaro, Valentina, Petazzoni, Greta, Mileto, Irene, Corbella, Marta, Asperges, Erika, Sacchi, Paolo, Rattotti, Sara, Varettoni, Marzia, Defrancesco, Irene, Cambieri, Patrizia, Baldanti, Fausto, Arcaini, Luca, Bruno, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223513/
https://www.ncbi.nlm.nih.gov/pubmed/37317279
http://dx.doi.org/10.3390/microorganisms11051305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223513/
https://www.ncbi.nlm.nih.gov/pubmed/37317279
http://dx.doi.org/10.3390/microorganisms11051305

Ejemplares similares